This Webinar will explain what 21 CFR Part 11 is, why it is essential to FDA-regulated companies, and how its conformance to Part 11 differs from having good IT security.
Procedures for controlling electronic signatures and electronic records as described in the FDA Guidance will be explained.
FDA-regulated companies want to transition to electronic records for economy and efficiency. FDA, because of its concern for patient safety, wants to prevent electronic records from being compromised with possible resulting harm to the patient. FDA has set up regulations that address both data security and patient safety. We will show how 21 CFR part 11 considers both.
The confusion over the original FDA regulation and its subsequent "selective enforcement" will be explained. FDA requirements for 21CFR Part 11 validation will be presented. the requirements are composed of technical and procedural aspects. open, closed, and hybrid (paper and electronic) systems will be explained.
Part of this fear originates from confusion. The FDA originally published a rather severe 21 CFR Part 11. After industry complaints, the FDA acknowledged that the regulation, as written, would result in nobody attempting to convert to electronic records. But, instead of rewriting the regulation, the FDA said it would "selectively enforce" sections of the regulation.
This webinar will explain what all this means. A 21CFR checklist and a Test protocol form will be given as handouts.
Part of this fear originates from confusion. The FDA originally published a rather severe 21 CFR Part 11. After industry complaints, the FDA acknowledged that the regulation, as written, would result in nobody attempting to convert to electronic records. But, instead of rewriting the regulation, the FDA said it would "selectively enforce" sections of the regulation.
This webinar will explain what all this means. A 21CFR checklist and a Test protocol form will be given as handouts.
Edwin Waldbusser
Edwin Waldbusser, is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the areas of design control, risk analysis and software validation for the past 8 years. Mr. Waldbusser has a BS in Mechanical Engineering and an MBA. He is a Lloyds of London certified ISO 9000 Lead Auditor and a member of the Thomson Reuters Expert Witness network.
Elevate Your Workplace Wellness: 10 Critical Wellness Facto…
The 60 Minutes Introduction to DAX
Launch Your Career: The Ultimate Guide for Emerging Profess…
Future-Proof Your Career: Upskilling Strategies to Stay Rel…
ChatGPT Unlocked: A Beginner’s Guide to AI and ChatGPT
DOL Reverses Course on Independent Contractor Rule for 2026…
Project Management for administrative professionals
ChatGPT for HR - Build HR Policy Framework and Strategy
Handbook Overhaul 2026: Compliance, OBBB Act & Beyond
Managing Toxic & Other Employees Who have Attitude Issues
EBITDA vs GAAP vs IFRS: What Your Business Needs to Know
Managing Difficult Employee Conversations
Harassment, Bullying, Gossip, Confrontational and Disruptiv…
Meeting Fatigue: Break the Cycle of Endless Meetings
Language is Code - Intro to AI - Generative AI - ChatGPT an…
From P-Values to Evidence: Interpreting Statistical Results…
High-Impact Performance Management: Tools, Tactics & Coachi…
Stop Letting That Difficult Person Ruin Your Day: Effective…
Mastering Tough Conversations: Turn Conflict into Clarity, …
AI for Project Managers: Smarter Planning Reporting and Com…
ChatGPT for Innovative Business Advisory Services for Accou…
Mastering Performance Management: Strategies for Continuous…
Latest Trends in Human Error Reduction in GMP Manufacturing
2-Hour Virtual Seminar on The Complexity and Interplay Amon…
Analytical Method Validation Under Good Laboratory Practice…
The Perfect Storm Coming to Healthcare: Value Based Care Me…
Fostering a Culture of Respect: Eliminating Gossip, Rumour…